Skip to main content
Atrás
VCEL logo

Vericel Corporation

Calidad de datos: 100%
VCEL
NASDAQ Healthcare Biotechnology
$32.45
▲ $1.04 (3.31%)
Cap. Mercado: 1.65B
Rango del Día
$31.51 $34.34
Rango de 52 Semanas
$29.24 $48.75
Volumen
695,481
Promedio 50D / 200D
$35.89 / $36.82
Cierre Anterior
$31.41

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (626 pares)

Métrica Acción Mediana del Sector
P/E 99.7 0.4
P/B 4.6 2.9
ROE % 5.1 3.8
Net Margin % 6.0 3.9
Rev Growth 5Y % 15.3 10.0
D/E 0.3 0.2

Puntos Clave

Revenue grew 15.32% annually over 5 years — strong growth
Earnings grew 59.41% over the past year
Debt/Equity of 0.28 — conservative balance sheet
Generating 24.75M in free cash flow
P/E of 99.73 — premium valuation
Cash machine — converts 149.82% of earnings into free cash flow

Crecimiento

Revenue Growth (5Y)
15.32%
Revenue (1Y)16.45%
Earnings (1Y)59.41%
FCF Growth (3Y)78.15%

Calidad

Return on Equity
5.11%
ROIC1.83%
Net Margin5.98%
Op. Margin4.00%

Seguridad

Debt / Equity
0.28
Current Ratio5.03
Interest Coverage7.10

Valoración

P/E Ratio
99.73
P/B Ratio4.64
EV/EBITDA148.99
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 16.45% Revenue Growth (3Y) 18.27%
Earnings Growth (1Y) 59.41% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 15.32% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 276.26M Net Income (TTM) 16.52M
ROE 5.11% ROA 3.39%
Gross Margin 74.42% Operating Margin 4.00%
Net Margin 5.98% Free Cash Flow (TTM) 24.75M
ROIC 1.83% FCF Growth (3Y) 78.15%
Safety
Debt / Equity 0.28 Current Ratio 5.03
Interest Coverage 7.10 Dividend Yield 0.00%
Valuation
P/E Ratio 99.73 P/B Ratio 4.64
P/S Ratio 5.96 PEG Ratio 1.93
EV/EBITDA 148.99 Dividend Yield 0.00%
Market Cap 1.65B Enterprise Value 1.65B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 276.26M 237.22M 197.52M 164.37M 156.18M
Net Income 16.52M 10.36M -3.18M -16.71M -7.47M
EPS (Diluted) 0.32 0.20 -0.07 -0.35 -0.16
Gross Profit 205.60M 172.11M 135.58M 109.79M 106.03M
Operating Income 11.04M 4.52M -6.46M -17.06M -7.85M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 487.97M 432.72M 353.66M 273.00M 243.71M
Total Liabilities 133.33M 140.76M 127.71M 80.73M 73.24M
Shareholders' Equity 354.64M 291.97M 225.95M 192.27M 170.46M
Total Debt 98.27M 98.85M 88.04M 47.57M 50.18M
Cash & Equivalents 100.09M 74.52M 69.09M 51.07M 68.33M
Current Assets 247.44M 212.78M 205.63M 186.87M 158.46M
Current Liabilities 49.15M 50.29M 45.75M 37.46M 26.05M